https://www.selleckchem.com/pr....oducts/LY2228820.htm
All patients presenting for POP should be evaluated for vaginal, bladder, bowel and sexualsymptoms including their goals for symptom treatment. This screening can be facilitated by a validatedPRO; however, most PROs provide more information than needed to provide clinical care and weredesigned for research purposes. All patients presenting for POP should be evaluated for vaginal, bladder, bowel and sexual symptoms including their goals for symptom treatment. This screening can be facilitated by a validated PRO; however, most PROs prov
Like
Comment
Share
